{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:41:45Z","timestamp":1777934505061,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2020,8,27]],"date-time":"2020-08-27T00:00:00Z","timestamp":1598486400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["J Oncol Pharm Pract"],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Low surface contamination levels of hazardous drugs in compounding areas can be used as indicators of exposure and efficacy of cleaning procedures. We report the efficacy results of the KIRO\u00ae Oncology self-cleaning automated compounding system for decontamination of cytotoxic drugs, assessed in an oncology health center using a sanitizing method and an alkaline method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study was conducted for six-days over a three-week period. A mixture with known levels of 5-fluorouracil, ifosfamide, cyclophosphamide, gemcitabine, etoposide, methotrexate, paclitaxel, docetaxel and carboplatin was added to the KIRO\u00ae Oncology\u2019s compounding area surface before each self-cleaning method was used. Contamination levels were determined, with a surface wipe sampling kit, at the end of the self-cleaning process.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Background surface contamination for quantified levels of cytotoxic drugs during routine use of KIRO\u00ae Oncology was below limit of quantification (&lt;LOQ) for all drugs, except for carboplatin, which has a very low LOQ (0.2\u2009ng\/sample). The quantified drug levels detected on surface wipe samples after self-cleaning using both methods in the KIRO\u00ae Oncology\u2019s compounding area surface sections were all &lt;LOQ when spiking with 1\u2009ng\/cm\n                      <jats:sup>2<\/jats:sup>\n                      (ten times the \u2018safe\u2019 reference value), except for carboplatin (alkaline method only), although its levels were still below the \u2018safe\u2019 reference value (0.1\u2009ng\/cm\n                      <jats:sup>2<\/jats:sup>\n                      ). For surface contamination levels when spiking with 100\u2009ng\/cm\n                      <jats:sup>2<\/jats:sup>\n                      , both self-cleaning methods had decontamination efficacies &gt;99.8% for all cytotoxic drugs analyzed.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides evidence on the efficacy of the KIRO\u00ae Oncology automatic self-cleaning system for surface area decontamination during the preparation of cytotoxic drugs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1078155220951866","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T01:44:50Z","timestamp":1598579090000},"page":"1343-1353","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation of the efficacy of a self-cleaning automated compounding system for the decontamination of cytotoxic drugs"],"prefix":"10.1177","volume":"27","author":[{"given":"Naiara","family":"Telleria","sequence":"first","affiliation":[{"name":"Pharmacy Department, KIRO Grifols S.L., Arrasate, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nerea","family":"Garc\u00eda","sequence":"additional","affiliation":[{"name":"Pharmacy Department, KIRO Grifols S.L., Arrasate, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaione","family":"Grisale\u00f1a","sequence":"additional","affiliation":[{"name":"Pharmacy Department, KIRO Grifols S.L., Arrasate, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiara","family":"Algaba","sequence":"additional","affiliation":[{"name":"Pharmacy Department, KIRO Grifols S.L., Arrasate, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eider","family":"Bergareche","sequence":"additional","affiliation":[{"name":"Pharmacy Department, KIRO Grifols S.L., Arrasate, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Tam\u00e9s","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy Department, Fundaci\u00f3n Onkologikoa, Donostia, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Cajaraville","sequence":"additional","affiliation":[{"name":"Hospital Pharmacy Department, Fundaci\u00f3n Onkologikoa, Donostia, Gipuzkoa, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,8,27]]},"reference":[{"key":"bibr1-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1177\/1078155217726160"},{"key":"bibr2-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1080\/15459624.2016.1165912"},{"key":"bibr3-1078155220951866","first-page":"703","volume":"53","author":"Schierl R","year":"2009","journal-title":"Ann Occup Hyg"},{"key":"bibr4-1078155220951866","first-page":"444","volume":"57","author":"Kiffmeyer TK","year":"2013","journal-title":"Ann Occup Hyg"},{"key":"bibr5-1078155220951866","first-page":"3","author":"Sessink PJM.","year":"2011","journal-title":"Saf Consid Oncol Pharm"},{"key":"bibr6-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1093\/annweh\/wxx065"},{"key":"bibr7-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1007\/s10661-016-5762-9"},{"key":"bibr8-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/56.14.1427"},{"key":"bibr9-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1191\/1078155205jp152oa"},{"key":"bibr10-1078155220951866","first-page":"603","volume":"49","author":"Mason HJ","year":"2005","journal-title":"Ann Occup Hyg"},{"key":"bibr11-1078155220951866","first-page":"619","volume":"49","author":"Crauste-Manciet S","year":"2005","journal-title":"Ann Occup Hyg"},{"key":"bibr12-1078155220951866","first-page":"611","volume":"49","author":"Acampora A","year":"2005","journal-title":"Ann Occup Hyg"},{"key":"bibr13-1078155220951866","first-page":"374","volume":"57","author":"Kopp B","year":"2013","journal-title":"Ann Occup Hyg"},{"key":"bibr14-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/59.1.68"},{"key":"bibr15-1078155220951866","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp050258"},{"key":"bibr16-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1177\/1078155210361431"},{"key":"bibr17-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1177\/1078155212468367"},{"key":"bibr18-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159052"},{"key":"bibr19-1078155220951866","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp160948"},{"key":"bibr20-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214551316"},{"key":"bibr21-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2012-000074.175"},{"key":"bibr22-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1177\/1078155214522840"},{"key":"bibr23-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1515\/pthp-2018-0018"},{"key":"bibr24-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1093\/annhyg\/mev031"},{"key":"bibr25-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1177\/1078155219843322"},{"key":"bibr26-1078155220951866","doi-asserted-by":"publisher","DOI":"10.1021\/ac00260a766"},{"key":"bibr27-1078155220951866","first-page":"456","volume":"57","author":"Queruau Lamerie T","year":"2013","journal-title":"Ann Occup Hyg"},{"key":"bibr28-1078155220951866","first-page":"407","volume":"70","author":"Ade A","year":"2017","journal-title":"Can J Hosp Pharm"}],"container-title":["Journal of Oncology Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155220951866","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1078155220951866","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1078155220951866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T02:23:38Z","timestamp":1777688618000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1078155220951866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,27]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10.1177\/1078155220951866"],"URL":"https:\/\/doi.org\/10.1177\/1078155220951866","relation":{},"ISSN":["1078-1552","1477-092X"],"issn-type":[{"value":"1078-1552","type":"print"},{"value":"1477-092X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,27]]}}}